All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Hims Cheaper Alternative 2026

Looking for a cheaper alternative to Hims for GLP-1 therapy in 2026? We compare the most affordable programs that still provide physician oversight.

By Dr. James Walker, MD, MPH|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. James Walker, MD, MPH · Reviewed by Dr. David Kim, MD, FACE

Hims Cheaper Alternative 2026 custom 2026 header image for Provider Comparisons
Custom header image for Hims Cheaper Alternative 2026, Provider Comparisons, and better treatment decision-making.
In This Article

This article is part of our Provider Comparisons collection. See also: GLP-1 Guides | Peptide Guides

Search and AI answer brief

Practical answer: Hims Cheaper Alternative 2026

Looking for a cheaper alternative to Hims for GLP-1 therapy in 2026? We compare the most affordable programs that still provide physician oversight.

Short answer

Looking for a cheaper alternative to Hims for GLP-1 therapy in 2026? We compare the most affordable programs that still provide physician oversight.

Search intent

This page answers a specific Provider Comparisons question rather than a generic overview.

What to verify

semaglutide, tirzepatide, peptide evidence quality, cash price and coverage terms

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

Looking for a cheaper alternative to Hims for GLP-1 therapy in 2026? We compare the most affordable programs that still provide physician oversight.

Hims advertises competitive pricing for their GLP-1 program, and the starting rates are genuinely reasonable. But what a lot of patients discover over time is that the cost of Hims increases as you titrate to higher doses. The monthly rate at your maintenance dose may be significantly higher than what attracted you to the platform in the first place.

When you multiply that difference over months or years of treatment, the math starts to matter. GLP-1 therapy isn't a short-term commitment for most patients. Finding a program that's affordable at month twelve, not just month one, is critical.

We evaluated the most cost-effective alternatives to Hims in 2026, focusing on programs that keep prices transparent and predictable while maintaining the medical oversight that makes GLP-1 therapy safe.

Why People Look for Cheaper Alternatives to Hims

The cost concern with Hims typically evolves over the course of treatment:

  • Starting price vs. maintenance price. The monthly cost at your initial dose may be $50 to $100 less than what you pay once you reach your maintenance dose. That increase catches many patients off guard.
  • Ongoing cost burden. At $200 or more per month for higher doses, the annual cost of Hims can exceed $2,400. For a medication you may need indefinitely, that number gets attention.
  • Value perception at scale. When provider interactions are brief and infrequent, paying premium prices for what feels like a prescription mill creates frustration.
  • Better deals available. The GLP-1 telehealth market has become increasingly competitive, and several programs now offer comparable or better care at lower price points.

Top Cheaper Alternatives to Hims in 2026

1. Henry Meds ($149/month)

Henry Meds is the price leader in the physician-supervised GLP-1 space. At $149/month for compounded semaglutide, the price is flat and all-inclusive. No consult fees, no shipping charges, no dose-dependent increases. What you pay in month one is what you pay in month twelve. For a complete cost breakdown, see our affordable GLP-1 options.

Top Telehealth GLP-1 Providers Compared Overall Value Score 0 23 46 69 92 92 78 75 70 FormBlends Hims/Hers Ro Calibrate Based on pricing, support, and patient outcomes
Top Telehealth GLP-1 Providers Compared. Based on pricing, support, and patient outcomes.
View data table
Bar chart showing top telehealth glp-1 providers compared: FormBlends (92), Hims/Hers (78), Ro (75), Calibrate (70)
CategoryOverall Value ScoreDetail
FormBlends92From $299/mo, physician-led
Hims/Hers78Consumer brand, varies
Ro75Telehealth platform
Calibrate70Metabolic health focus
Illustration for Hims Cheaper Alternative 2026

The clinical model is simplified. You get monthly provider check-ins and access to support, but this isn't a program built for patients who need intensive medical management. For patients who are responding well to semaglutide and primarily need a reliable, affordable source of medication with basic oversight, Henry Meds is hard to beat on value.

Pros:

  • $149/month flat rate at every dose level
  • All costs included, no hidden fees
  • Simple enrollment and fast shipping
  • No contracts

Cons:

  • Basic medical oversight
  • No lab monitoring
  • Limited to semaglutide
  • Less personalized care

2. FormBlends ($199/month)

FormBlends costs more than the cheapest options, but the per-dollar value is arguably stronger. At $199/month for compounded semaglutide (or $249/month for tirzepatide), you get physician-supervised care that's genuinely personalized. Your physician builds your protocol around your response, adjusts dosing based on how you're doing, and is available when you have questions.

The critical difference from Hims on pricing: FormBlends uses flat-rate pricing. Your monthly cost doesn't increase as you titrate to higher doses. For patients on higher-dose protocols, FormBlends may actually be cheaper than Hims despite the higher starting price.

FormBlends also offers peptide therapies that Hims doesn't, giving patients access to BPC-157 and other compounds under the same physician relationship.

Pros:

  • Flat-rate pricing that doesn't increase with dose
  • Genuine physician supervision
  • Access to peptide therapies
  • No contracts or hidden fees

Cons:

  • $50/month more than the cheapest options at starting doses
  • Smaller platform

3. SkinnyRx ($149+/month)

SkinnyRx keeps things simple and affordable. The program focuses exclusively on weight loss medications, skips the extras, and passes the savings through to patients. Enrollment is quick, the platform is straightforward, and the pricing is competitive at every dose level.

Pros:

  • Competitive starting prices
  • Focused, no-frills approach
  • Fast enrollment process

Cons:

  • Less clinical oversight
  • No peptide therapy
  • Limited medication selection

4. Ro Body ($149+/month)

Ro starts at a competitive price and includes lab monitoring that most platforms skip. The clinical value at the starting price is excellent. The catch is the same one Hims has: costs increase as you titrate. At maintenance doses, Ro can be comparable to or more expensive than Hims. But if the lab monitoring and clinical rigor matter to you, the additional cost may be justified.

Pros:

  • Lab monitoring included at no extra charge
  • Strong medical oversight
  • Competitive starting price

Cons:

  • Costs increase at higher doses
  • May not save money long-term vs. Hims
  • Not available in every state

5. MEDVi ($149+/month)

MEDVi offers GLP-1 telehealth at price points comparable to Hims, with a more focused weight loss orientation. The savings over Hims depend on your specific dose and plan, but MEDVi is generally competitive. The clinical experience is a slight step up from Hims' high-volume model, though not as personalized as physician-led programs like FormBlends.

Pros:

  • Competitive pricing
  • More focused on weight loss than Hims' broader platform
  • Physician consultations included

Cons:

  • May not be significantly cheaper than Hims
  • Mixed reviews on customer support
  • No peptide options

Cost Comparison Table

Program Starting Price Maintenance Dose Price Price Structure Hidden Fees Contracts
Henry Meds $149/mo $149/mo Flat rate None None
FormBlends $199/mo $199/mo Flat rate None None
SkinnyRx $149/mo Varies Tiered None None
Ro Body $149/mo $249+/mo Tiered None None
MEDVi $149/mo Varies Tiered Varies None

Who Should Switch from Hims to Save Money

Switching GLP-1 providers to save money makes the most sense in these scenarios:

Not sure which GLP-1 is right for you?

Take a 2-minute assessment and get a personalized recommendation after licensed provider review.

Take the Assessment →
  • You're on a higher dose and your Hims cost has increased. If your monthly payment has gone up $50 or more since you started, a flat-rate program could save you $600 or more per year.
  • You're stable and don't need intensive oversight. If your protocol is working and you just need reliable medication delivery, a lower-cost option like Henry Meds provides exactly that.
  • You want better value, not just a lower price. Sometimes spending the same amount (or slightly more) at a program like FormBlends gets you significantly more physician engagement, which can produce better results and reduce long-term treatment costs.
  • You're planning to stay on GLP-1 therapy long-term. The longer you expect to be on medication, the more important monthly cost becomes. A $75/month savings adds up to $900 per year.

Frequently Asked Questions

Why does Hims charge more at higher doses?

Higher doses require more medication per injection, which increases the pharmacy cost. Some programs absorb that cost and offer flat-rate pricing. others pass it through to patients. Hims uses a tiered model where price increases with dose.

Is the cheapest GLP-1 program the best choice?

Not necessarily. The cheapest program is the best choice if it provides adequate medical oversight and uses quality compounding pharmacies. Below a certain price point, programs may cut corners on clinical care or pharmacy standards. Look for the best value, not just the lowest number.

Will I get the same medication at a cheaper program?

Compounded semaglutide contains compounded formulations of the active ingredient regardless of which telehealth platform prescribes it. What varies is the compounding pharmacy, the formulation details, and the quality standards. Programs that work with FDA-registered 503B compounding facilities provide the most reliable medication quality.

Can I keep my current dose when I switch to a cheaper provider?

Yes, in most cases. Your new provider will review your treatment history and continue you at your current dose if clinically appropriate. There's no medical reason to restart at a lower dose simply because you changed providers.

Key Points

Hims isn't overcharging relative to the market, but their tiered pricing model means your costs grow as your dose increases. In 2026, several alternatives offer flat-rate pricing or lower overall costs while maintaining the physician oversight that keeps GLP-1 therapy safe. Whether you go with the lowest possible price or the best overall value depends on your priorities.

Want physician-supervised GLP-1 therapy at a predictable price? FormBlends offers flat-rate monthly pricing, personalized care, and peptide therapy options. No dose-based price increases, no contracts. See what your plan would look like.

Talk to a licensed provider

Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.

Start the assessment →

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Calibrate official source
Official source
Henry Meds official source
Official source
Hers official source
Official source
Hims official source
Official source
MEDVi official source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Hims Cheaper Alternative 2026, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

Hims Cheaper Alternative 2026 should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

After comparing, use the get-started flow to route your goals and health history into the right prescription review path.

FormBlends Editorial Context

Reviewed May 14, 2026

Looking for a cheaper alternative to Hims for GLP-1 therapy in 2026? We compare the most affordable programs that still provide physician oversight. "Hims Cheaper Alternative 2026" is most useful when you treat it as decision prep, not a shortcut. The page is built around comparison and decision support, with the highest-value checks sitting around the main claim, safety boundary, and next practical step. Because this article has 6 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. If the answer affects treatment, cost, pharmacy choice, or dosing, bring the specifics to a licensed clinician before acting.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Hims Cheaper Alternative 2026

This update makes Hims Cheaper Alternative 2026 more specific by tying semaglutide, tirzepatide, BPC-157, cash-pay pricing, safety signals, hims to the page's original clinical, cost, access, or comparison angle.

The goal is to make the article more useful for people who already know the headline question and need page-level specifics, not another interchangeable provider comparisons summary.

For 2026 review, the content emphasizes current verification, treatment fit, and patient-safety questions that can be discussed with a qualified provider.

Hims Cheaper Alternative 2026 custom 2026 image for provider comparisons on FormBlends

Custom 2026 image for Hims Cheaper Alternative 2026, provider comparisons, and better treatment decision-making.

Image description: Unique image for this page covering Hims Cheaper Alternative 2026, provider comparisons, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Disclosure: FormBlends is one of the providers discussed in this article. Our editorial team independently researches and verifies all pricing and claims. Pricing was last verified in March 2026. Read our editorial policy.

Written by Dr. James Walker, MD, MPH

Internal Medicine. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.